President Biden (AP Images)
June 17, 2021 11:13 AM EDTUpdated 11:24 AM
Coronavirus

Biden in­vests $3B in­to an­tivi­ral de­vel­op­ment for Covid-19

Zachary Brennan

Senior Editor

The Biden ad­min­is­tra­tion on Thurs­day un­veiled a new plan to in­vest more than $3 bil­lion in­to speed­ing new an­tivi­rals to treat Covid-19.

The plan will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

A service from the Financial Times